Clinical experience with the Xomed Audiant osteointegrated bone conducting hearing device: a preliminary report of seven cases.

An osteointegrated bone conducting hearing device has recently become available in North America. As with any new medical treatment, initial enthusiasm is soon tempered by its inherent limitations. Critical and objective analysis of results and candid reporting of clinical experiences will lead to the establishment of realistic indications for any new treatment. We present the current indications for insertion of the Xomed Audiant Bone Conductor, our early clinical experience and our thoughts on its future role in the management of patients with conductive hearing loss.